Las Vegas, NV -- (SBWIRE) -- 01/15/2014 -- Value Stock Pick is a leading Investment Newsletter. Our Research Team conducts research on different stocks, doing their due diligence to provide a detailed report, including both technical and fundamental analysis, on NYSE, NASDAQ, AMEX, OTCBB and Pink Sheet Stocks. Let’s have a brief look at: Generex Biotechnology Corporation (OTCMKTS:GNBT), The Western Union Company (NYSE:WU), Alpha Natural Resources, Inc. (NYSE:ANR), Peregrine Pharmaceuticals (NASDAQ:PPHM).
Generex Biotechnology Corporation (OTCMKTS:GNBT) ended its recent business day with the tumbled of -10.04% and closed at the price of $0.0430 after opening at $0.04. The stock traded during its last trading session with the total volume of 7.83 million shares, as compared to its average volume of 5.31 million shares. Generex Biotechnology Corporation, a development stage company, is engaged in the research, development, and commercialization of drug delivery systems and technologies for metabolic and immunological diseases.
Has GNBT Found The Bottom And Ready To Gain Momentum? Find Out Here
The Western Union Company (NYSE:WU) remained among the day bullish 0.85% and traded with volume of 11.77 million shares in the last session, as compared to average volume of 5.83 million shares. In comparison with 52 week range of $13.24 - $19.50, it faced lowest price of $16.19 during the last trading session whereas its day highest price was $16.55. The company’s total market capitalization is $9.12 billion, along with 552.25 million shares outstanding. The Western Union Company provides money movement and payment services worldwide.
Will WU Continue To Move Higher? Find out via this report
Alpha Natural Resources, Inc. (NYSE:ANR) showed 9.58 million shares in volume during the last trading session, while the average trading volume remained 12.06 million shares. The stock kicked off its trading session at $6.19 and closed at $6.13 after dropped -0.16%. Alpha Natural Resources, Inc., together with its subsidiaries, engages in extracting, processing, and marketing steam and metallurgical coal in Virginia, West Virginia, Kentucky, Pennsylvania, and Wyoming.
Will ANR Get Buyers Even After The Recent Rally? Find Out Here
Peregrine Pharmaceuticals (NASDAQ:PPHM) stock traded during its last trading session with the total traded volume of 6.44 million shares versus its average volume of 2.77 million shares. The company opened its trade at the price of $1.85 and its closing price was $1.72 after fell -3.37% for the day. Peregrine Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of monoclonal antibodies focused on the treatment and diagnosis of cancer.
Has PPHM Found The Bottom and Ready To Move Up? Find Out Here
PLEASE NOTE WELL: The employees of ValueStockPick.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site, Press releases or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Please Read Our Full Disclaimer at http://www.valuestockpick.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)